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Abstract 
Introduction: One of the forms of inflammatory bowel disease (IBD) that causes inflammation and ulcers in colon 
is ulcerative colitis (UC). This study was aimed to determine the epidemiological and clinical aspects of patients with 
ulcerative colitis in the west of Iran.
Methods: In this cross sectional study, we evaluated 150 patients with definite diagnosis of UC who referred to a 
subspecialty gastroenterology clinic in Khorramabad, Iran. The study was performed from May 2014 to August 2015 
by using census method. Demographic characteristics as well as patients’ clinical profiles were extracted using a 
checklist. Disease severity was determined by the Truelove and Witt’s classification of ulcerative colitis (UC). Data were 
analyzed using SPSS software, version 17 for windows (IBM Inc., NY, US).
Results: A total of 150 patients with definite diagnosis of UC were analyzed, including 84 (56 %) women and 
66 (44 %) men (male/female ratio = 1.27). The mean age of patients was 33.7 ± 12.5 years with an age range of 
17–98 years. The age of the majority of patients was 20–29 and most of them (56 %) were women and living in urban 
areas (70.7 %). The most common site of the involvement in colon was rectosigmoid (66 patients, 44 %). Severity of 
the disease was mild in 36 patients (24.1 %), moderate and severe in 74 and 40 patients (49.3 and 26.6 %), respectively. 
The most common clinical manifestation of the patients was dysentery (68 %) and then rectorrhagia (60 %). Only 12 
of all patients (7.8 %) mentioned a positive family history of IBD in their first degree kinfolks. Ten patients (6.7 %) had a 
history of regular smoking and four of them (2.6 %) mentioned a history of appendectomy. Four patients (5.3 %) had a 
positive history of smoking by their mothers during their pregnancy.
Conclusion: The results of this study demonstrate differences and similarities in demographic and clinical character-
istics of UC in this part of Iran in comparison to other parts of the country.
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Background
Inflammatory bowel disease (IBD) is known as a group 
of inflammatory conditions (signs and symptoms) of the 
colon and small intestine. Ulcerative colitis (UC) and 
Crohn’s disease (CD) are the most important types of 
IBDs. IBD causes the bowel (intestine) to be inflamed, 
swollen, irritated and unable to function in a healthy 
way. UC is a form of IBDs that leads to inflammatory and 
ulcerative lesions in the colon. It affects large intestine 
(the colon) and rectum but does not involve the small 
intestine; whereas CD affects both the colon and small 
intestine (Torpy et  al. 2012; Danese and Fiocchi 2011). 
Although considerable progresses have been made in 
IBD research, but researchers are yet to determine the 
exact etiology of the disease. Some studies suggested that 
this disease involves a complex interaction of factors such 
as a variety of genetic, immunologic and environmental 
factors (Shirazi et al. 2013a) (4 Website). Diarrhea mixed 
with blood is the main symptom of the active form of 
the disease and the other symptoms are usual such as 
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mucous stool, abdominal pain and extra-intestinal mani-
festations (Torpy et al. 2012; Li et al. 2015). UC is char-
acterized by recurring episodes of inflammation limited 
to the mucosal layer of the colon. It is a relapsing and 
remitting disorder with disease free intervals (Thoreson 
and Cullen 2007). The incidence and prevalence of UC 
depend on geographic location and ethnicity. UC has an 
incidence rate of 1–20 cases per 100,000 individuals/year, 
and a prevalence of 8–246/100,000 individuals (Danese 
and Fiocchi 2011). IBD is reportedly more common in 
developed countries than developing countries. However, 
according to some recent studies, the prevalence of IBD is 
on the increase in developing nations in the past two dec-
ades (Thia et al. 2008; Balaii et al. 2015). The total num-
ber of new cases of UC each year in  North America  is 
10–12/100,000  individuals/year. It is common in people 
between the ages of 15 and 25. The number of affected 
individuals is 1–3/1000 (Busch et  al. 2014). The disease 
affects females more than males (Hanauer 1996). The 
geographic distribution of UC and CD is similar world-
wide (Podolsky 2002) with the highest incidences in the 
United States, Canada, the United Kingdom, and Scan-
dinavia. Higher incidences are seen in northern climates 
as compared with southern climates in Europe (Shi-
vananda et al. 1996) and the United States (Sonnenberg 
et al. 1991). Studies of Asians in Asia show relatively low 
incidence rates for UC and CD as compared with North 
America and Europe. The prevalence of both UC and CD 
in Japan and Korea is relatively low (Yang et  al. 2001). 
Although the evidence is insufficient, there are reports 
of the growing incidence of UC in the Middle East (Sid-
dique et al. 2012; Abdul-Baki et al. 2007a, b; Aghazadeh 
et al. 2005a). Recently, the incidence rate in Arab popu-
lation was reported to be 22/100,000 (El Mouzan et  al. 
2006; Lennard-Jones 1989; Khan et al. 1996; Contractor 
et  al. 2004). Moreover, a recent retrospective study in 
Saudi Arabia reported an increase in the number of UC 
patients who were referred to tertiary care centers (Ala-
min et al. 2001; Alharbi et al. 2014). Another retrospec-
tive study on Libyan children showed that the incidence 
of IBD was increasing and the clinical features were simi-
lar to those reported in other countries (Ahmaida and 
Al-Shaikhi 2009). Similar to other parts of Asia, previous 
reports from Iran have demonstrated an increasing inci-
dence of IBD, particularly UC, in this region (Mir-Mad-
jlessi et  al. 1985; Vahedi et  al. 2009b; Aghazadeh et  al. 
2005a; Daryani et  al. 2006). Certain lifestyle and socio-
economic conditions in combination with Genetic and 
Immunologic factors seem to be involved in the develop-
ment of UC. In addition, a familial incidence of UC has 
been recognized for many years, and about 10–20  % of 
patients have at least one other family member that is 
affected by UC. A number of environmental risk factors 
have been proposed to be associated with UC, such as 
diet, food additives, Appendectomy, oral contraceptive, 
cigarette smoking, alcohol abuse and so forth. Some 
studies have indicated that cigarette smoking and Appen-
dectomy may have a protective role against the develop-
ment of UC (López-Serrano et al. 2010). Despite previous 
reports from Iran have suggested increasing incidence of 
UC, there is limited data regarding the characteristics of 
these patients and disease course in Iran. This study was 
conducted to determine the epidemiological and clinical 
characteristics of UC in Khorramabad, Iran, from May 
2014 to August 2015.
Methods
The present study was performed from May 2014 to 
August 2015 using census method. A total of 150 patients 
with UC, who were referred to a subspecialty clinic of 
gastroenterology sequentially in Khorramabad, Iran were 
included in this study. They were diagnosed of UC based 
on clinical manifestations, colonoscopy, stool examina-
tion and pathologic confirmation. In order to prevent 
breaches of patient’s privacy, clinical history and labo-
ratory evaluations were recorded with no name or tel-
ephone number.
Ethical aspects
The study protocol was in accordance with the Dec-
laration of Helsinki for investigation involving human 
subjects and was approved by the ethics committee of 
Lorestan University of Medical Sciences, Khorramabad, 
Iran.
Exclusion criteria
Patients with incomplete data were excluded from the 
study.
Data collection
To gather information about the patients, personal inter-
view was carried out by a gastroenterologist and the 
obtained information was recorded in a questionnaire. 
The patients’ age, sex, clinical symptoms, disease dura-
tion, history of smoking, oral contraceptive use, appen-
dectomy and a positive family history of IBD in their 
first degree kinfolks were recorded in the first part of 
the questionnaire. The second part of the questionnaire 
included information about clinical aspects of the disease 
such as intestinal and extra intestinal manifestations, 
disease severity, the site of colon involvement based on 
colonoscopic findings and kind of drugs used. To evalu-
ate some of the extra intestinal manifestations in addition 
to history taking and physical examination, some of the 
laboratory tests, and liver, gall bladder, kidney and uri-
nary tract sonography were requested for all the patients. 
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Disease severity was determined using the Truelove and 
Witt’s classification of UC.
Statistical analysis
Data were analyzed using SPSS software, version 17 for 
windows (IBM Inc., NY, US). Descriptive tests were used 
as appropriated.
Results
In this study, a total of 150 patients diagnosed with 
UC were evaluated. Out of the 150 patients examined, 
84 (56  %) were women and 66 (44  %) were men (male/
female ratio =  1.27). The mean age of the patients was 
33.7 ± 12.5 years with an age range of 17–98 years. The 
age range of majority of the patients in this study was 
20–29 (38.7  %). Most of them (56  %) were women and 
living in urban areas (70.7  %). The educational level of 
most of them was high school and Diploma (48 %). The 
frequency distribution of the demographic characteris-
tics of the patients is shown in Table 1. The mean age at 
disease onset was 29.4 ± 12.1 years and the mean dura-
tion from the first symptom of the disease to the defi-
nite diagnosis was 18.9  months. Relapse occurred in 50 
patients (33.3  %). Based on colonoscopic findings, the 
most common site of colon involvement was rectosig-
moid (66 patients, 44 %). Rectum involvement was seen 
in 38 patients (25.3 %), left colon and pan colon involve-
ment were seen, respectively in 26 and 20 patients (17.3 
and 13.3 %). In terms of severity of the disease based on 
colonoscopy, disease severity was mild in 36 patients 
(24.1 %), moderate and severe, respectively in 74 and 40 
patients (49.3 and 26.6  %). The most common clinical 
manifestation of the patients in this study was dysentery 
(68  %), followed by rectorrhagia (60  %). The frequency 
distribution of clinical signs and symptoms of the disease 
is shown in Table 2. Extra intestinal manifestations were 
seen in 22 patients (14.3 %) of which the most common 
of them were aphthous ulcers with 2.6 % each. Hepato-
billiary symptoms were the most common extra intes-
tinal manifestation with 6.7 % (Table 3). In terms of the 
kind of treatment, majority of the patients (21.3 %) were 
treated with mesalamine and asacol Suppositories. Thus 
18.7, 13.3 and 17.3  % of the patients took only asacol, 
combination of corticosteroids, mesalamine and asa-
col and combination of corticosteroids and mesalamine, 
respectively. Four patients (2.6 %) required surgery. Only 
12 among all patients (7.8 %) mentioned a positive family 
history of IBD in their first degree kinfolks. Ten patients 
(6.7 %) had a history of regular smoking and four of them 
(2.6  %) mentioned a history of appendectomy. Majority 
of the patients (37.3  %) were second child in their fam-
ily and the mean age of their mothers as at the time of 
their pregnancy was 29.1 years. Four patients (5.3 %) had 
a positive history of smoking by their mothers during 
their pregnancy. With regards to delivery type, 24  % of 
the patients were through C/S and only 66 patients (44 %) 
were breastfed and the other patients were fed by formu-
las and other milks (Table 4).   
Discussion
UC is a chronic disease of the colon (also known as the 
large intestine) associated with inflammation of the lining 
of colon and development of tiny open sores, or ulcers, 
which produce mucous and pus. The combination of 
ulceration and inflammation can cause abdominal dis-
comfort and also frequent emptying of the colon. The dis-
ease is the result of an abnormal response by the immune 
system of the body. The cells and proteins which make 
Table 1 frequency distribution of  individual characteris-











 <20 12 (8) (8)
 20–29 58 (38.7) (46.7)
 30–39 34 (22.7) (69.3)
 40–49 30 (20) (89.3)
 ≥50 16 (10.7) (100)
Sex
 Male 66 (44) (44)
 Female 84 (56) (100)
Marriage status
 Single 104 (69.3) (69.3)
 Married 42 (28) (97.3)
 Others 4 (2.7) (100)
Literacy
 Uneducated 16 (10.7) (10.7)
 Primary and sec-
ondary
30 (20) (30.7)
 High school 72 (48) (78.7)
 Academic 32 (21.3) (100)
Job
 Unemployed 12 (8) (8)
 Worker 4 (2.7) (10.7)
 Clerk 6 (4) (14.7)
 Farmer 8 (5.3) (19.7)
 Housewife 70 (46.7) (66.4)
 Free 46 (30.7) (97.3)
 Military 4 (2.7) (100)
Residency
 Urban 106 (70.7) (70.7)
 Rural 44 (29.3) (100)
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up the immune system, normally protect the individual 
from infections. However, in people with IBD, food, bac-
teria and other materials are mistaken for antigen by the 
immune system. Hence, the body sends white blood cells 
into the lining of the intestines and cause chronic inflam-
mation and ulcerations. The present study was conducted 
to assess the clinic-epidemiological characteristics and 
colonoscopic findings of UC in Khorramabad city from 
May 2014 to August 2015. UC most commonly begins 
between the ages of 15 and 25. Also,  another usual age 
of the onset is in the 6th decade of life. Females are more 
likely to be affected than males (Büsch et al. 2014). In this 
study, the mean age of the patients was 33.7 ± 12.5 years 
with an age range of 17 to 98  years. The percentage of 
affected women with a shade was higher than men, and 
this is in line with the results of several studies conducted 
in Iran and across the globe (male/female ratio =  1.27). 
In a study on the demographic and clinical features of 
UC patients in Kerman, the mean age of the patients 
was reported as 33.3  years and the sexual proportion 
of males to females was 0.8–1 (Zahedi et  al. 2009). In 
another study, the mean age of the patients was 32 years 
and the percentage of affected women with a shade was 
higher than men (Abdul-Baki et al. 2007a, b). Keshavarz 
and Izadi (2008) found the mean age of the patients to be 
34  years and the sexual proportion of males to females 
as 1.08, indicating that the percentage of the men with a 
shade was higher than women in this study. The dispar-
ity in findings between the present study and other stud-
ies can be attributed to the difference in sample content 
of the studies and number of patients used. The mean age 
at onset of the disease in this study was 29.4 years and the 
mean duration from the first symptom of the disease to 
the definite diagnosis was 18.9  months. The long dura-
tion from symptomatic to definite diagnosis in the pre-
sent study may be attributed to lack of gastroenterologists 
in the province, and the referring of patients to general 
physicians’ clinics and delay in diagnosis. In the present 
study, relapse occurred in 33.3 % of the patients. In most 
cases, improper attention to the given orders and irregu-
lar drug use by the patients were the reasons for the fre-
quent disease relapse. The most and least common site of 
colon involvement in this study were rectosigmoid and 
pan colon, respectively. This finding is consistent with 
the results of previous studies (Aghazadeh et  al. 2005b; 
Farmer et al. 1993; Keshavarz and Izadi 2008). In a study 
Portela et  al. (2010) in southern European countries, 
it was reported that the most common site of involve-
ment was the left colon. Pan colon involvement was seen 
in 28 % of cases in this study. With regards to the site of 
colon involvement, there is a relative similarity between 
the results of the present study and other studies. The rea-
son for the difference in site of colon involvement may be 
due to the difference in disease pathogenesis in different 
places in the world or could be attributed to the fact that 
colonoscopy is performed by different persons in world 
and that sometimes, the gastroenterologist may not have 
performed this test to determine the exact length of the 
involved colon. In a study conducted in China on 389 
patients with UC, the disease severity was recorded as 
Table 2 Frequency distribution of  clinical manifestations 
of ulcerative colitis in studied patients








Abdominal pain (56) (37.3)
Defecation with pain (82) (54.7)
Incomplete defecation (62) (41.3)
Vomiting (12) (8)
Weight loss (78) (52)
Melena (6) (4)
Anemia (40) (26.7)
Anal fistula (10) (6.7)
Fever (12) (8)
Weakness/fatigue (60) (40)








Kidney stone (2) (1.3)
Gall bladder stone (2) (1.3)
Arthritis (2) (1.3)




Deep vein thrombosis (2) (1.3)
Aphthous ulcers (4) (2.6)
Fatty liver (2) (1.3)
Table 4 Frequency of involved segments of colon






Left colon 26 (17.3)
Pan colon 20 (13.3)
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moderate and severe in 52.4 and 13.4  % of the patients, 
respectively (Jiang et al. 2006), and this is consistent with 
the results of the present study, as the disease severity of 
49.3 % of patients was considered as moderate. In the pre-
sent study, the most common clinical manifestations seen 
in patients were dysentery and rectorrhagia. In a study 
conducted on Epidemiological and clinical characteristics 
of IBD in patients from northwestern Iran, it was shown 
that the most common clinical manifestations of patients 
with UC were abdominal cramp and rectorrhagia (Shirazi 
et al. 2013b), whereas in the present study, the most com-
mon clinical manifestations were dysentery and rector-
rhagia. The most common extra intestinal manifestations 
in the present study were aphthous ulcers, but in general, 
hepatobiliary manifestations were the most common 
form of extra intestinal involvement in this study. Nota-
bly, 14.3 % of our patients had extra intestinal manifesta-
tions. Aghazadeh et al. (2005b) and Vahedi et al. (2009a) 
reported that 31.4 and 62.4 % of their patients had extra 
intestinal manifestations, respectively. While in a study 
by Jiang and Cui (2002), the frequency of extra intestinal 
manifestations was determined as 6.1  %. The disparity 
in findings between the present study and other stud-
ies can be attributed to fewer number of sample con-
tent in the present study and the inability to evaluate all 
the extra intestinal manifestations in the patients. With 
regards to family history, in the present study, the family 
history of IBD in the first degree kinfolks of the patients 
was 7.8  %. In a study conducted by Bahari et  al. (2004), 
6.5  % of the patients had a positive history of smoking, 
which is consistent with the results of the present study. 
In study byYazdanbod et al. (2011), the family history of 
IBD in the first degree kinfolks of the patients were 10.9 
and 5.4 %, respectively. De Saussure et al. (2007), in their 
study, reported a prevalence of appendectomy in patients 
with UC and control group as 12 and 46 %, respectively 
demonstrating that appendectomy is a protective factor 
against UC. Whereas, in the present study, only 2.7 % of 
patients had a history of appendectomy.
Conclusion
Ulcerative colitis is one of the important referral causes 
of patients to the subspecialty clinics of gastroenterology 
and unofficial records demonstrate increasing incidence 
of cases of this disease in Iranian race that may be due to 
changing of people´s life style and following the life style 
of western communities and developing of diagnostic 
and treatment instruments of the disease.
Altogether, it seems that the epidemiologic profile and 
clinical characteristics of UC in our country, Iran, have a 
relative similarity to other places in the world, but clinical 
development of the disease is milder and extra intestinal 
manifestations are fewer; on the other hand, evaluation of 
all sides of the disease may have an important role to rec-
ognize real factors causing the disease and prevent from 
them. The high rate of frequent relapse of the disease in the 
patients requires more attention to their treatment and to 
make them pay attention to the correct and regular medi-
cine taking. Since Khorramabad is the center of Lorestan 
province in which rather all patients from another parts of 
the province are referred to there, this city could be repre-
sentative of population of the west of Iran; in addition there 
are some other deprived provinces such as Ilam in the west 
of Iran that the patients of theirs are also referred to Khor-
ramabad to get better services. The results of this study, 
demonstrate differences and similarities in demographic 
and clinical profile of UC in this part of Iran in comparison 
to other parts of the country. Some other limitations of the 
present study were the short duration of the evaluation of 
the disease and few numbers of the studied patients.
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